Chad Winters
Fortuna: 518 941 $ al 31/07/2026
Fortuna: 518 941 $ al 31/07/2026
Chad R.
Winters is currently Chief Accounting Officer & VP-Finance at West Pharmaceutical Services, Inc. since 2024.
Former positions include Director at La Causa, Inc. and Controller, Senior VP-Finance & Accounting at Amneal Intermediate, Inc. Education includes an undergraduate degree from Villanova University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/04/2026 | 1.522 ( 0 % ) | 518 941 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Comptroller/Controller/Auditor | 01/10/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Comptroller/Controller/Auditor | - |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Health Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.